Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels: Direct Labeling Using a Novel Fluorescent Diltiazem Analog

Thomas Brauns, Wolfgang Berger, Stanislav Berjukov, Steffen Hering, Hartmut Glossmann, Jörg Striessnig, Zhen Wei Cai, Spencer Kimball, Hee Chol Kang, Richard P. Haugland

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We have synthesized a series of N-propylamino-substituted benzazepinones (NPSBs) as specific probes for the benzothiazepinone (BTZ) binding domain of muscle L-type calcium channels (LTCCs). NPSBs were identified which possess high affinity for the channel after purification. We synthesized a fluorescent NPSB, DMBODIPY-BAZ, as the first benz(othi)azepinone derivative known to reversibly label partially purified LTCCs. DMBODIPY-BAZ binds to the partially purified channel with high affinity (Kd = 25 nM, 5max = 580 pmol/mg of protein). Fluorescence resonance energy transfer (FRET) occurred between tryptophan residues of the channel protein and the DMBODIPY fluorophore upon specific drug binding. FRET was exploited to allow highly time-resolved detection of specific drug binding kinetics. We found that the dissociation half-life (t1/2) of DMBODIPY-BAZ decreased with the concentration of an unlabeled competitor, which indicates ligand-induced accelerated dissociation. In contrast, t1/2 was concentration-dependently increased by the dihydropyridine (DHP) (+)-isradipine. These kinetic properties of DMBODIPY-BAZ indicate that a high-affinity BTZ binding domain also exists on purified LTCCs. NPSBs represent novel tools to provide further insight into the molecular pharmacology of the BTZ binding domain on LTCCs.

Original languageEnglish (US)
Pages (from-to)3461-3469
Number of pages9
JournalBiochemistry
Volume34
Issue number10
DOIs
StatePublished - Jan 1 1995

Fingerprint

L-Type Calcium Channels
Diltiazem
Labeling
Fluorescence Resonance Energy Transfer
Isradipine
Kinetics
Fluorophores
Tryptophan
Pharmaceutical Preparations
Purification
Half-Life
Muscle
Labels
Proteins
Pharmacokinetics
Pharmacology
Ligands
Derivatives
Muscles

All Science Journal Classification (ASJC) codes

  • Biochemistry

Cite this

Brauns, T., Berger, W., Berjukov, S., Hering, S., Glossmann, H., Striessnig, J., ... Haugland, R. P. (1995). Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels: Direct Labeling Using a Novel Fluorescent Diltiazem Analog. Biochemistry, 34(10), 3461-3469. https://doi.org/10.1021/bi00010a039
Brauns, Thomas ; Berger, Wolfgang ; Berjukov, Stanislav ; Hering, Steffen ; Glossmann, Hartmut ; Striessnig, Jörg ; Cai, Zhen Wei ; Kimball, Spencer ; Kang, Hee Chol ; Haugland, Richard P. / Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels : Direct Labeling Using a Novel Fluorescent Diltiazem Analog. In: Biochemistry. 1995 ; Vol. 34, No. 10. pp. 3461-3469.
@article{69d485da8e8241f89ca536b90a172782,
title = "Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels: Direct Labeling Using a Novel Fluorescent Diltiazem Analog",
abstract = "We have synthesized a series of N-propylamino-substituted benzazepinones (NPSBs) as specific probes for the benzothiazepinone (BTZ) binding domain of muscle L-type calcium channels (LTCCs). NPSBs were identified which possess high affinity for the channel after purification. We synthesized a fluorescent NPSB, DMBODIPY-BAZ, as the first benz(othi)azepinone derivative known to reversibly label partially purified LTCCs. DMBODIPY-BAZ binds to the partially purified channel with high affinity (Kd = 25 nM, 5max = 580 pmol/mg of protein). Fluorescence resonance energy transfer (FRET) occurred between tryptophan residues of the channel protein and the DMBODIPY fluorophore upon specific drug binding. FRET was exploited to allow highly time-resolved detection of specific drug binding kinetics. We found that the dissociation half-life (t1/2) of DMBODIPY-BAZ decreased with the concentration of an unlabeled competitor, which indicates ligand-induced accelerated dissociation. In contrast, t1/2 was concentration-dependently increased by the dihydropyridine (DHP) (+)-isradipine. These kinetic properties of DMBODIPY-BAZ indicate that a high-affinity BTZ binding domain also exists on purified LTCCs. NPSBs represent novel tools to provide further insight into the molecular pharmacology of the BTZ binding domain on LTCCs.",
author = "Thomas Brauns and Wolfgang Berger and Stanislav Berjukov and Steffen Hering and Hartmut Glossmann and J{\"o}rg Striessnig and Cai, {Zhen Wei} and Spencer Kimball and Kang, {Hee Chol} and Haugland, {Richard P.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1021/bi00010a039",
language = "English (US)",
volume = "34",
pages = "3461--3469",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "10",

}

Brauns, T, Berger, W, Berjukov, S, Hering, S, Glossmann, H, Striessnig, J, Cai, ZW, Kimball, S, Kang, HC & Haugland, RP 1995, 'Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels: Direct Labeling Using a Novel Fluorescent Diltiazem Analog', Biochemistry, vol. 34, no. 10, pp. 3461-3469. https://doi.org/10.1021/bi00010a039

Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels : Direct Labeling Using a Novel Fluorescent Diltiazem Analog. / Brauns, Thomas; Berger, Wolfgang; Berjukov, Stanislav; Hering, Steffen; Glossmann, Hartmut; Striessnig, Jörg; Cai, Zhen Wei; Kimball, Spencer; Kang, Hee Chol; Haugland, Richard P.

In: Biochemistry, Vol. 34, No. 10, 01.01.1995, p. 3461-3469.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Benzothiazepinone Binding Domain of Purified L-Type Calcium Channels

T2 - Direct Labeling Using a Novel Fluorescent Diltiazem Analog

AU - Brauns, Thomas

AU - Berger, Wolfgang

AU - Berjukov, Stanislav

AU - Hering, Steffen

AU - Glossmann, Hartmut

AU - Striessnig, Jörg

AU - Cai, Zhen Wei

AU - Kimball, Spencer

AU - Kang, Hee Chol

AU - Haugland, Richard P.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - We have synthesized a series of N-propylamino-substituted benzazepinones (NPSBs) as specific probes for the benzothiazepinone (BTZ) binding domain of muscle L-type calcium channels (LTCCs). NPSBs were identified which possess high affinity for the channel after purification. We synthesized a fluorescent NPSB, DMBODIPY-BAZ, as the first benz(othi)azepinone derivative known to reversibly label partially purified LTCCs. DMBODIPY-BAZ binds to the partially purified channel with high affinity (Kd = 25 nM, 5max = 580 pmol/mg of protein). Fluorescence resonance energy transfer (FRET) occurred between tryptophan residues of the channel protein and the DMBODIPY fluorophore upon specific drug binding. FRET was exploited to allow highly time-resolved detection of specific drug binding kinetics. We found that the dissociation half-life (t1/2) of DMBODIPY-BAZ decreased with the concentration of an unlabeled competitor, which indicates ligand-induced accelerated dissociation. In contrast, t1/2 was concentration-dependently increased by the dihydropyridine (DHP) (+)-isradipine. These kinetic properties of DMBODIPY-BAZ indicate that a high-affinity BTZ binding domain also exists on purified LTCCs. NPSBs represent novel tools to provide further insight into the molecular pharmacology of the BTZ binding domain on LTCCs.

AB - We have synthesized a series of N-propylamino-substituted benzazepinones (NPSBs) as specific probes for the benzothiazepinone (BTZ) binding domain of muscle L-type calcium channels (LTCCs). NPSBs were identified which possess high affinity for the channel after purification. We synthesized a fluorescent NPSB, DMBODIPY-BAZ, as the first benz(othi)azepinone derivative known to reversibly label partially purified LTCCs. DMBODIPY-BAZ binds to the partially purified channel with high affinity (Kd = 25 nM, 5max = 580 pmol/mg of protein). Fluorescence resonance energy transfer (FRET) occurred between tryptophan residues of the channel protein and the DMBODIPY fluorophore upon specific drug binding. FRET was exploited to allow highly time-resolved detection of specific drug binding kinetics. We found that the dissociation half-life (t1/2) of DMBODIPY-BAZ decreased with the concentration of an unlabeled competitor, which indicates ligand-induced accelerated dissociation. In contrast, t1/2 was concentration-dependently increased by the dihydropyridine (DHP) (+)-isradipine. These kinetic properties of DMBODIPY-BAZ indicate that a high-affinity BTZ binding domain also exists on purified LTCCs. NPSBs represent novel tools to provide further insight into the molecular pharmacology of the BTZ binding domain on LTCCs.

UR - http://www.scopus.com/inward/record.url?scp=0028987710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028987710&partnerID=8YFLogxK

U2 - 10.1021/bi00010a039

DO - 10.1021/bi00010a039

M3 - Article

C2 - 7880840

AN - SCOPUS:0028987710

VL - 34

SP - 3461

EP - 3469

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 10

ER -